全文获取类型
收费全文 | 316501篇 |
免费 | 27688篇 |
国内免费 | 10511篇 |
专业分类
耳鼻咽喉 | 2440篇 |
儿科学 | 4431篇 |
妇产科学 | 3625篇 |
基础医学 | 49039篇 |
口腔科学 | 6328篇 |
临床医学 | 24459篇 |
内科学 | 51162篇 |
皮肤病学 | 4789篇 |
神经病学 | 24046篇 |
特种医学 | 7603篇 |
外国民族医学 | 79篇 |
外科学 | 23897篇 |
综合类 | 42207篇 |
现状与发展 | 35篇 |
一般理论 | 6篇 |
预防医学 | 17628篇 |
眼科学 | 3162篇 |
药学 | 47906篇 |
113篇 | |
中国医学 | 13735篇 |
肿瘤学 | 28010篇 |
出版年
2024年 | 839篇 |
2023年 | 5546篇 |
2022年 | 12305篇 |
2021年 | 15042篇 |
2020年 | 11733篇 |
2019年 | 12507篇 |
2018年 | 11845篇 |
2017年 | 11007篇 |
2016年 | 10420篇 |
2015年 | 12234篇 |
2014年 | 19323篇 |
2013年 | 20340篇 |
2012年 | 18064篇 |
2011年 | 20559篇 |
2010年 | 17181篇 |
2009年 | 17889篇 |
2008年 | 16571篇 |
2007年 | 15900篇 |
2006年 | 14071篇 |
2005年 | 12093篇 |
2004年 | 9468篇 |
2003年 | 8550篇 |
2002年 | 6747篇 |
2001年 | 5628篇 |
2000年 | 4727篇 |
1999年 | 4227篇 |
1998年 | 3937篇 |
1997年 | 3632篇 |
1996年 | 3279篇 |
1995年 | 2961篇 |
1994年 | 2697篇 |
1993年 | 2335篇 |
1992年 | 1964篇 |
1991年 | 1808篇 |
1990年 | 1499篇 |
1989年 | 1259篇 |
1988年 | 1225篇 |
1987年 | 1061篇 |
1986年 | 1123篇 |
1985年 | 1820篇 |
1984年 | 1797篇 |
1983年 | 1230篇 |
1982年 | 1269篇 |
1981年 | 1044篇 |
1980年 | 957篇 |
1979年 | 748篇 |
1978年 | 483篇 |
1977年 | 415篇 |
1976年 | 425篇 |
1975年 | 273篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
肝素钠软膏(海普林)治疗皮质类固醇激素依赖性皮炎疗效观察 总被引:3,自引:0,他引:3
目的观察肝素钠软膏(海普林)治疗皮质类固醇激素依赖性皮炎的效果。方法随机抽取部分病例组成对照组,其余病例组成治疗组,分别使用单纯乳剂和肝素钠软膏外涂,配合相关内服药物治疗,比较治疗组和对照组疗效。结果对照组治疗有效率为24.81%,治疗组治疗有效率为52.24%,两组结果差异有非常显著性。结论应用肝素钠软膏外用治疗皮质类固醇激素依赖性皮炎取得了满意的疗效。 相似文献
992.
Sofya N Pchelina Andrei F Yakimovskii Olga N Ivanova Anton K Emelianov Andrei H Zakharchuk Alexander L Schwarzman 《Movement disorders》2006,21(12):2234-2236
Among mutations associated with autosomal dominant and sporadic Parkinson's disease (PD) the G2019S substitution in the leucine-rich repeat kinase 2 (LRRK2) gene is the most frequently identified. To estimate its frequency in Russia, we analyzed 208 patients with PD from the Northwestern region of Russia. Of these, 51 patients were probands from families with PD compatible with autosomal dominant inheritance. The control group represented 161 subjects without neurological disorders settled in the same region. The frequency of the G2019S mutation was greater in familial PD (2 [3.9%] of 51) than in sporadic PD (1 [0.6%] of 157). In addition, this mutation was found in the proband's father, who also had PD, in 1 PD family, and in 1 carrier without signs of PD at age 40 in another PD family. All carriers were heterozygous for the G2019S mutation and reported the Ashkenazi Jewish origin. The mutation was not found in the control group. 相似文献
993.
为筛选大叶紫薇叶中具有降血糖活性的成分,采用3T3-L1细胞葡萄糖消耗模型作为检测手段,对大叶紫薇叶提取物采用HP-20树脂吸附、溶剂萃取、制备薄层分离和制备高效液相分离,导向筛选具有降血糖作用的各分离组分.结果发现,大叶紫薇叶中corosolic acid、熊果酸和总三萜具有降血糖活性. 相似文献
994.
P. Botas E. Delgado G. Castaño C. Díaz de Greñu J. Prieto F. J. Díaz-Cadórniga 《Diabetic medicine》2003,20(11):904-908
AIMS: To estimate the prevalence of diabetes mellitus with three diagnostic criteria (WHO-1985 and 1999 and ADA-1997), evaluate their concordance and analyse the sensitivity and specificity of the different screening strategies for diabetes. METHODS: A cross-sectional population study with two-step sampling. One thousand and 34 people were selected randomly. A 75-g oral glucose tolerance test (OGTT) was performed and venous blood samples were obtained fasting and at 2 h. RESULTS: The prevalence of known Type 2 diabetes mellitus (DM-2) is 4%[95% confidence interval (CI) 2.8, 5.1]. By WHO-1985 criteria the prevalence of unknown DM-2 is 5.9% (4.5, 7.4); by ADA-1997 criteria 3.5% (2.5, 4.6) and by WHO-1999 criteria 7.3% (5.8, 8.8). Diagnostic overlap and statistical concordance (coefficient K) are WHO-1985/ADA-1997 29.3%, K=0.42; WHO-1985/WHO-1999 80%, K=0.88; ADA-1997/WHO-1999 48%, K=0.63. If only fasting glucose was used (following ADA-1997), 36.3% of those with diabetes (2-h glucose > or =11.1 mmol/l) would be diagnosed. If OGTT was performed (i) in those with a fasting glucose between 6.1 mmol/l and 6.9 mmol/l (9.8% of the population) we would diagnose 66.6%, and (ii) in all those between 5.7 mmol/l and 6.9 mmol/l (18.9% of the population) 81.8% would be diagnosed. CONCLUSIONS: The ADA criteria decrease the prevalence of DM in the adult population of Asturias by 2.4% and concordance with the classical criteria (WHO-1985) was only 29.3%. Using fasting glucose only (ADA-1997) diagnoses 36.3% of those with diabetes. The recent recommendations of the WHO-1999 increases this to 66.6%. To improve the diagnostic strategy for diabetes and detect up to 81.8% of patients, we propose the use of OGTT for all those with a fasting glucose between 5.7 mmol/l and 6.9 mmol/l. 相似文献
995.
A D Kriketos D G Carey A B Jenkins D J Chisholm S M Furler L V Campbell 《Diabetic medicine》2003,20(4):294-300
AIMS: To examine the relationships between body composition and changes in fasting glycaemia, and in indices of insulin secretion and insulin action over 6 years in females with a family history of Type 2 diabetes with or without prior gestational diabetes ('at risk' group, AR) and control females (control group, C). METHODS: At baseline and at follow-up, an oral glucose tolerance test and dual energy X-ray absorptiometry assessment of body composition were performed. Indices of insulin resistance (HOMA R') and insulin secretion (HOMA beta') were obtained from fasting insulin and glucose concentrations. RESULTS: At baseline, the groups were similar for age, body mass index, fasting levels of plasma glucose and insulin, HOMA R' and HOMA beta'. Despite similar total body fatness, AR had significantly greater waist circumference and central fat (both P < 0.02) compared with C. At follow-up there was a significant increase in central adiposity only in AR, and the fasting plasma glucose (FPG) level was higher in AR compared with C (5.0 +/- 0.2 vs. 4.3 +/- 0.2 mmol/l, P = 0.02). This rise in plasma glucose in AR was related to a decline in HOMA beta' (r = 0.45, P = 0.0065). Both the baseline and the increments in total and central abdominal fat mass were associated with the time-related decline in HOMA beta'. CONCLUSIONS: Six years after initial assessment, AR showed deterioration in FPG levels due predominantly to a decline in insulin secretion index without major change in insulin resistance index. Importantly, baseline body fatness (especially central adiposity), as well as increases in fatness with time, were the major predictors of the subsequent decline of insulin secretion index and the consequent rise in FPG. 相似文献
996.
儿童髓母细胞瘤中ERBB-2的表达 总被引:2,自引:1,他引:1
目的:探讨ERBB-2在儿童髓母细胞中的表达及临床意义.方法:用免疫组织化学LSAB法检测84例获随访的儿童髓母细胞瘤中的ERBB-2表达,按术后生存期3、5、10年分为A、B、C三组.使用Cox回归统计分析.结果:84例儿童髓母细胞瘤中,ERBB-2阳性表达72例(85.71%),A、B、C三组间ERBB-2阳性表达分别为100%,88.9%,40%(P<0.01),Cox回归分析显示ERBB-2是影响生存时间的一个独立的预后因子,它与预后存在负相关关系.结论:ERBB-2表达水平可作为儿童髓母细胞瘤的预后指标之一. 相似文献
997.
998.
999.
原位心脏移植30例临床分析 总被引:7,自引:0,他引:7
目的对30例心脏移植进行分析总结。方法30例患者中,24例的原发病为扩张型心肌病,4例为终末期瓣膜性心肌病,1例为终末期缺血性心肌病,1例为病毒性心肌炎行双心室辅助术后1个月。均在体外循环下行原位心脏移植术,3例采用标准心脏移植术式,27例采用双腔静脉吻合心脏移植术式,体外循环时间(75±24)min,主动脉阻断时间(72±8)min。术后采用环孢素A、霉酚酸酯和泼尼松预防排斥反应,根据血环孢素A的浓度调整CsA的用量。术后早期,每天行心肌内心电图及超声心动多普勒监测,以便早期发现急性排斥反应,必要时行心内膜心肌活检。结果30例患者中,术后死亡5例,3例死于低心排,1例死于感染所致的多器官功能衰竭,1例死于出血。术后并发症有低心排、心律失常、三尖瓣返流、右心衰竭、细菌和真菌感染、肾功能异常及血糖升高,上述并发症除导致死亡者外,其余经治疗好转;4例发生急性排斥反应,给予甲泼尼龙冲击治疗,并调整免疫抑制剂的用量后排斥反应逆转。结论术后并发症的预防和及时正确的处理,是心脏移植成功的关键,尤其是对感染、急性排斥反应、右心功能不全及肾功能异常的预防和处理。 相似文献
1000.
目的初步探讨血管生成素-2(Angiopoietin-2,Ang-2)在食管鳞状细胞癌组织中的表达及其与肿瘤病理分级、浸润和转移的关系。方法采用S-P免疫组织化学方法,对85例食管鳞癌及22例正常食管组织中的Ang-2表达水平进行检测,并与肿瘤病理分级、浸润深度及淋巴结转移情况进行统计学分析。结果85例食管鳞癌组织中,57例Ang-2表达呈阳性,阳性率为67.06%,显著高于Ang-2在正常食管组织中的表达(P<0.05)。Ang-2表达与肿瘤病理分级和淋巴结转移显著相关(P<0.05)。结论Ang-2的表达与食管鳞癌的临床分期及病理分级呈正相关,提示Ang-2促进肿瘤新生血管形成,参与食管鳞癌的发生和发展,可作为反映食管癌进展的生物学指标。 相似文献